LENZ Therapeutics's total assets for Q1 2025 were $201.25M, a decrease of -6.53% from the previous quarter. LENZ total liabilities were $9.24M for the fiscal quarter, a -17.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.